COFEPRIS for US Supplement Brands: The Complete 2026 Compliance Playbook

The anxiety is legitimate. Here's what actually happens.

You've built a supplement brand that works. You're doing $3M, maybe $10M, in the US. Someone on your team mentioned Mexico, you Googled it, and now you're drowning in PDFs from regulatory consultants who all want $8,000 just to tell you whether your product qualifies.

That's a real problem. This guide exists to solve it.

COFEPRIS registration is the single biggest operational hurdle for US supplement brands entering Mexico. It's not optional, not a formality, and not the same as FDA approval. It's a structured, predictable process that thousands of brands have completed, with timelines and costs you can actually know before you commit a dollar.

I'm going to cover every stage, every cost, every failure mode, and every edge case. By the end, you'll know whether Mexico is right for your product, what it will actually cost you, and how to avoid the mistakes that add six months to a launch.

---

Why Mexico is creating anxiety for supplement founders right now

65 million online buyers. That's the size of Mexico's addressable ecommerce audience according to AMVO's 2024 report, growing at a pace the US market hasn't seen since 2015. The country's ecommerce market sits at $43-55B (AMVO), with health and wellness consistently ranking as one of the top three purchase categories on both Amazon Mexico and MercadoLibre.

The opportunity is obvious. The anxiety comes from what founders don't know, and from the fact that the regulatory system is genuinely different in ways that aren't obvious until they bite you.

Most US supplement founders have built their regulatory muscle around FDA's DSHEA framework. They understand structure/function claims, they know what a Supplement Facts panel requires, and they have a reasonable sense of what they can and cannot say on a label. Mexico runs on an entirely different system. Different agency, different classification logic, different labeling standards, and a product approval mechanism with no direct US equivalent.

The fear isn't irrational. Get it wrong and you've got inventory stuck at customs, a regulatory violation on your MercadoLibre or Amazon Mexico listing, or worse, a product that COFEPRIS reclassifies as a drug rather than a food supplement. That reclassification alone can kill a launch.

What follows is the complete playbook. Read it in order the first time, then use the section headings to work through the process when you're deep in it.

For a broader orientation on what the Mexico supplement market actually looks like competitively, the supplement market intelligence report is the right starting point before you read a single regulatory document.

---

What the regulations actually say (not what you've heard)

Mexico's supplement regulatory framework governs 3 distinct product categories under the Ley General de Salud and Normas Oficiales Mexicanas such as NOM-086-SSA1-1994, and misreading which one applies to your product is the most expensive mistake US founders make. COFEPRIS (Comisión Federal para la Protección contra Riesgos Sanitarios) is the agency that enforces it. Think of COFEPRIS as Mexico's FDA, but with different jurisdiction lines and a classification system that does not map cleanly onto US categories.

The classification problem that trips up everyone

I want to spend real time here because this is where I see the most expensive mistakes.

The most consequential decision in Mexico supplement compliance is classification. Under Mexican law, your product falls into one of these categories:

A suplemento alimenticio is a food supplement. This is where most US vitamins, minerals, proteins, and herbal blends land. It requires a registration process called a Registro Sanitario and is governed by NOM-086-SSA1-1994 and related Normas Oficiales Mexicanas.

A medicamento herbolario is an herbal medicine. This applies to plant-based products that make therapeutic claims or contain ingredients COFEPRIS has designated as medicinal. The registration pathway is longer, more expensive, and requires clinical or bibliographic evidence.

A remedio herbolario is a traditional herbal remedy. Less common for US brands, but relevant if your product contains specific traditional Mexican botanical ingredients.

Here's where founders get burned: your US label language frequently implies the wrong category. "Clinically studied," "supports immune defense," "pharmaceutical grade", these phrases push a product toward medicamento classification even if the underlying formula is a straightforward vitamin blend. COFEPRIS reviewers read labels carefully and they have significant discretion. I've watched a clean magnesium glycinate product get flagged because the label copy used the word "therapeutic." That's a rewrite and a delay, not a death sentence, but it's avoidable.

The COFEPRIS classification guide for US brands covers the exact boundary cases in detail, and the supplement vs. medicine classification post gives you a framework for evaluating your own SKUs before you file anything.

What a Registro Sanitario actually is

A Registro Sanitario (RS) is the product-level authorization that allows a suplemento alimenticio to be legally sold in Mexico. It's issued by COFEPRIS and is product-specific, manufacturer-specific, and label-specific. Change the formula, change the label, or change the manufacturer, and you may need a modification or a new registration.

The RS number appears on your Mexican label. Retailers and marketplaces require it. Customs officers check for it. It is the foundational document of your Mexico compliance stack.

The aviso de funcionamiento: the step most brands skip

Before a Registro Sanitario, you need an Aviso de Funcionamiento, the business-level notification to COFEPRIS that your facility, or your Mexican importer's facility, exists and handles regulated products. It's not an inspection or approval. It's closer to a business registration with the health authority.

Most US brands skip this because their Mexican distributor says they'll handle it. Sometimes that's true. Often it doesn't get done at all, which creates a compliance gap that surfaces during customs clearance or marketplace listing verification.

It's a free filing. There's no excuse for missing it. The aviso de funcionamiento explained post covers the process in full.

NOM-051 and what it means for your label

NOM-051-SCFI/SSA1-2010 (and its 2020 update) governs food and beverage labeling in Mexico. It requires warning seals ("sellos de advertencia") on products that exceed threshold levels for calories, sugars, saturated fat, sodium, and trans fat. For most supplement formats, capsules, powders, softgels, the sello requirements are less commonly triggered than they are for food products. Gummies, ready-to-drink formulas, and protein bars frequently cross the thresholds.

The NOM-051 complete guide covers the full framework. The NOM-051 for US brands post covers the Phase 3 timeline going into effect in 2027-2028, which will affect additional product categories.

For supplement brands specifically: the NOM-051 label must be in Spanish, must follow specific font size and hierarchy requirements, and the Información Nutrimental panel (equivalent to US Nutrition Facts) must meet Mexican formatting standards. Your US label is not compliant by default. Not even close.

Ingredients that don't cross the border

Mexico uses a positive list approach for supplement ingredients, ingredients that aren't explicitly permitted require additional review. The relative openness of the US market around novel ingredients doesn't apply here. The banned ingredients post covers the specific compounds that create problems, including several adaptogenic herbs, high-dose single nutrients, and synthetic compounds common in US performance supplements.

The 7 products you can't sell in Mexico post gives specific examples. Read it before you decide which SKUs to launch with, it will save you from a painful conversation six months into the process.

---

The COFEPRIS registration process, step by step

The Registro Sanitario process runs 4 to 18 months across 7 distinct stages, each with a responsible party, a timeline, and a cost. The table below reflects real data from supplement brand launches processed through Tally Global's Mexico operations team.

Stage 1: Product classification review (weeks 1-2)

Before filing anything, you need a written opinion on how your product will be classified. This is internal diligence, not a COFEPRIS filing. You or your Mexican regulatory consultant reviews the formula, the label claims, and the ingredient list against current COFEPRIS guidance.

Cost: $500-$1,500 if done by a consultant. Zero if you have the regulatory expertise in-house, which most US brands don't.

Output: a classification memo that determines whether you file as suplemento alimenticio or another category, and flags any ingredients that need substitution or documentation.

Don't skip this because it feels like paying for something you already think you know. Founders who skip it and file directly are the ones who end up with requerimientos on ingredients they didn't know were flagged.

Stage 2: Mexican legal entity or importer setup (weeks 2-8)

A Registro Sanitario must be held by a Mexican legal entity. You have 2 paths.

Path A is your own S. de R.L. de C.V., the Mexican equivalent of an LLC. This requires an RFC (Registro Federal de Contribuyentes, Mexico's tax ID), an eFirma (formerly FIEL, the digital signature used for government filings with SAT), a registered address, and a notarized formation document. Timeline: 6-10 weeks. Cost: $2,500-$5,000 in legal and notary fees.

Path B is a Mexican importer or distributor holding the RS. You contract with a Mexican company that already has COFEPRIS standing and agrees to hold your Registro Sanitario. Faster and cheaper upfront, but it creates a dependency I'll cover in detail in the failure modes section below. That dependency is more serious than most founders realize until they're in it.

Most $1M-$10M brands start with Path B and migrate to Path A once they have revenue. Brands above $10M with serious Mexico intentions should go straight to Path A.

The Mexico expansion guide for 65 million buyers covers the entity decision in the context of broader market entry strategy.

Stage 3: Technical dossier preparation (weeks 3-8, runs parallel)

The Registro Sanitario application requires a technical dossier. For a suplemento alimenticio, this typically includes:

The fórmula cuali-cuantitativa (QQ), the full ingredient list with exact quantities per serving. More detailed than a US Supplement Facts panel. Every excipient, coating, flow agent, and capsule material must be listed.

The análisis bromatológico, a laboratory analysis confirming the nutritional composition of the product, from a COFEPRIS-recognized lab or an accredited lab with verifiable results.

A Certificate of Free Sale. Your US product may have one from the FDA or your state health department. Worth saying explicitly: this does not equal COFEPRIS approval and does not automatically accelerate your application. It's one supporting document among many.

Manufacturing facility documentation, proof that your US manufacturer operates under GMP standards. An FDA GMP inspection record or NSF/ISO certification is acceptable.

A draft Mexican label, a mock-up in compliance with NOM-051 and NOM-086 requirements, in Spanish, with the RS placeholder where the number will appear once issued.

A power of attorney, required if a consultant files on your behalf.

Dossier preparation is where timelines slip, and it's almost never the consultant's fault. US manufacturers are often slow to provide facility documentation. The QQ formula may reveal an ingredient issue that requires reformulation. Draft labels require back-and-forth with your regulatory consultant.

Realistic preparation time: 4-8 weeks if you're organized. 12-16 weeks if your manufacturer takes three weeks to return emails.

Stage 4: COFEPRIS filing (weeks 8-12)

The application is filed through COFEPRIS's digital portal (SIGEN). Filing fees are set by the federal government and are modest compared to the total cost of compliance.

These are government fees only. Consultant fees to prepare and file the dossier are separate.

Stage 5: COFEPRIS review and response (weeks 12-36)

After filing, COFEPRIS has a statutory review period. In practice:

Standard pathway: 60 business days (approximately 12-14 weeks). This is the stated timeline. Reality varies considerably.

With a requerimiento (request for additional information): add 30-60 business days after you respond. COFEPRIS reviewers frequently issue requerimientos for missing documents, label corrections, or QQ clarifications. Each one restarts a portion of the clock.

Medicated or borderline products: 90-120 business days minimum, sometimes longer.

The COFEPRIS registration timeline post covers real data from 200 US brand launches. The median supplement RS takes 6-9 months from initial filing to approval. The fastest clean filings take 4 months. Contested or complicated dossiers can take 18 months.

That range is real. I'm not padding it to set low expectations, I've seen both ends of it. Plan for the middle.

Stage 6: RS issued, label finalized, inventory produced (weeks 36-42)

Once the RS is issued, you have an RS number. Your label can be finalized with that number printed, not stickered, if possible. Your Mexican label must appear on the product before it enters Mexico through a formal import channel.

For most US brands, this means either printing a separate Mexican label to apply at the warehouse, or co-manufacturing a Mexico-specific SKU with the label printed directly. The sticker approach works operationally but adds per-unit cost and creates quality control issues that compound as volume grows.

Stage 7: Import clearance and first shipment (weeks 42-48+)

With the RS in hand, you can import through a formal IOR (Importer of Record) structure. The IOR is the Mexican legal entity responsible for customs clearance. They file the pedimento aduanal (customs declaration) and pay the derechos de importación (import duties).

The IOR approval post covers what the first shipment actually looks like operationally. It is more involved than US brands expect, and it's the moment where under-prepared brands lose weeks, sometimes at significant landed cost.

---

Timeline and costs: real data from real launches

Full cost breakdown: single SKU Mexico launch

Those $8,000 consultant quotes you received aren't scams. They're fair market price for a full-service dossier on a complex product. Simpler products with clean formulas and an experienced consultant can hit the low end.

Timeline by product type

The gummy vitamin category deserves specific attention. OLLY has 24,800 reviews on Amazon Mexico while every other brand sits under 400, according to Datahooks category analysis. That gap exists partly because most brands haven't completed the regulatory process, not because Mexican consumers don't want gummies. The gummy vitamin opportunity in Mexico and the gummy vitamin market CAGR post quantify the opening.

The T1 exemption: test before you commit

Before you have a Registro Sanitario, you can import small quantities for personal use under the T1 courier importation exemption, up to roughly $1,000 USD worth of product per shipment via international courier (DHL, FedEx, etc.) without formal customs clearance.

The T1 is not a sales channel. You cannot fulfill customer orders this way. It's a tool for getting product into Mexico for market research, gifting to potential retail buyers, or validating demand before committing to the full RS process.

Brands that skip this step and go straight to full import sometimes discover a demand signal problem after spending $20,000 on compliance. Test cheaply first.

---

What can go wrong (and how to prevent it)

A single misstep here, a mislabeled claim or a missing document, can add 30 to 60 business days to your timeline. This is the section most compliance guides skip: they sell you the process, they don't tell you where it breaks.

The requerimiento spiral

A requerimiento pauses your application clock and requires a formal response within a set period. Miss the response window and the application closes, you start over from filing.

More dangerous: a requerimiento often reveals a structural problem in the dossier that requires substantive changes, not just missing documents. A poorly translated QQ formula. A label claim COFEPRIS reads as therapeutic. An ingredient quantity that exceeds the permitted level.

I've watched a brand spend 4 months preparing a dossier, get a requerimiento on week two of review for a label hierarchy issue that took 3 days to fix, then wait 45 more business days for the clock to restart. The fix was minor. The delay was not.

Prevention: use a Mexican regulatory consultant who has filed supplement RSs recently, not one who primarily does food or cosmetic registrations. Ask for their requerimiento rate. A consultant who never gets requerimientos is probably being overly conservative in the dossier. One who gets them on every filing doesn't know current COFEPRIS interpretation. A rate of 20-30% is normal.

The distributor RS trap

Letting a Mexican distributor hold your Registro Sanitario is faster and cheaper at entry. It's also a significant dependency that founders consistently underestimate until they're in a bad situation.

The RS is held in their name, not yours. If the relationship sours, if they go out of business, or if they use the RS to bring in competing product, and this happens, you have no direct recourse. You cannot pull the RS. You cannot transfer it without their cooperation. You're stuck.

Mitigation: if you use a distributor RS holder, include contractual provisions requiring them to support an RS transfer within 90 days of written request, and get a copy of all filing documents from day one. The doing it yourself vs. hiring a distributor comparison covers the full tradeoff analysis.

The US label assumption

This one is consistent enough that I'm going to be direct: your US label is not close to compliant. Not even directionally close.

The Información Nutrimental panel uses different formatting. The serving size language must be in Spanish and follow Mexican conventions. Net content is metric units only. The importer's name, address, and RFC must appear on the label. The RS number must appear once issued. The NOM-051 sello analysis result must be reflected.

Founders who build their Mexico timeline assuming the label needs minor translation end up adding 6-8 weeks they didn't budget for. Creating a compliant Mexican label from scratch takes 2-4 weeks with a designer who knows the NOM-051 requirements. The Mexico isn't Canada post covers the most expensive assumptions US brands bring to the market.

Customs holds

Even with a valid RS and compliant label, shipments can be held at customs. Common triggers: label language that doesn't match the RS exactly (even minor discrepancies), product arriving ahead of the label artwork update, HS code classification disputes where the COFEPRIS classification and the customs HS code don't align, and documentation gaps on the pedimento aduanal.

The landed cost difference between a smooth IOR clearance and a held shipment is significant. The IOR vs. T1 landed cost comparison uses pet food numbers but the cost structure is nearly identical for supplements.

The SENASICA confusion

If your supplement contains any animal-derived ingredients, collagen, fish oil, whey, bone broth, SENASICA (www.gob.mx/senasica) may have concurrent jurisdiction. SENASICA is the agricultural and animal health regulator, entirely separate from COFEPRIS. Products that cross both jurisdictions need documentation from both agencies.

Most supplement founders don't know SENASICA exists until a customs officer asks for a SENASICA certificate on a shipment of collagen peptides. That's a bad moment to learn about it. The SENASICA vs. COFEPRIS post covers where the jurisdictional lines are drawn.

Monthly tax obligations nobody mentions upfront

If you form a Mexican S. de R.L. de C.V., you have monthly tax filing obligations with SAT. Mexico taxes monthly, not annually. Every month, your entity files a declaración covering IVA (Mexico's VAT, currently 16%) and ISR (income tax) obligations. Missing filings triggers automatic fines.

This is not optional, not something you can batch once a year, and not something a US accountant can handle without Mexico-specific experience. Budget for a Mexican accountant ($300-$600/month) from day one. The monthly tax filing post covers what to expect.

---

Selling on Amazon Mexico and MercadoLibre: the platform layer

Getting the RS is not the end of compliance. Selling into Mexico's $43-55B ecommerce market adds a second layer of requirements, and Amazon Mexico suppresses supplement listings that lack a valid RS number, so skipping this step effectively means no sales.

Amazon Mexico listing requirements

Amazon Mexico (Amazon.com.mx) requires the RS number in the product listing for supplement categories, and listings without a valid RS will be suppressed or removed. The real cost of selling on Amazon Mexico covers the full unit economics including FBA fees, referral fees, and PPC costs.

Amazon Mexico PPC costs for supplements are meaningfully lower than US equivalents, but the category is less developed. The Amazon Mexico PPC cost for pet supplements provides a useful structural benchmark for thinking about ACOS and break-even at different monthly ad spend levels.

MercadoLibre requirements

MercadoLibre is larger than Amazon in many Mexican categories. The MercadoLibre for US brands post covers the platform mechanics. For supplements, MercadoLibre also requires RS documentation for health product listings. Enforcement varies by category but has been tightening.

The US brands not showing up

According to Datahooks' 2025 Amazon Mexico catalog analysis, a significant percentage of US supplement brands with strong US presence have zero or near-zero Mexican market presence. The US brands absent from Amazon Mexico post documents the gap. That's the competitive window, the shelf space that exists because their regulatory process is still pending or never started.

---

The decision framework: is Mexico right for your brand right now?

Not every brand should enter Mexico in 2026. Here's an honest read on when to go and when to wait.

Go if: your product has a clean formula with ingredients on Mexico's permitted list; you have at least $50,000 available for compliance, launch, and working capital; your US packaging is modular enough to support a Spanish-language label version; you have 12-18 months before you need Mexican revenue to matter; and you have someone, on your team or contracted, who can manage the Mexican entity's monthly obligations.

Wait if: your flagship product contains an ingredient likely to trigger a requerimiento or a medicamento classification review (if your hero SKU has ashwagandha at clinical doses, don't lead with it, launch a simpler product first and run ashwagandha through the process in parallel); your working capital is tight and a 6-month RS delay would create a real business problem; you have no relationships or partners in Mexico and no budget to build them; or your unit economics only work at US-level volume and you haven't validated Mexican demand.

The worst decision is doing nothing while competitors move. The cost of waiting analysis is direct about this: the brands currently winning on Amazon Mexico and MercadoLibre didn't have a regulatory advantage. They started earlier. Every month of RS timeline they already completed is a month you now have to work through too, except with less shelf space available when you arrive.

OLLY's 24,800 review gap in the gummy vitamin category didn't happen overnight. The US brands absent from Amazon Mexico post quantifies what the delay has already cost some brands.

---

The COFEPRIS compliance stack: what you actually need

A complete Mexico compliance stack has 9 documents, from an Aviso de Funcionamiento that clears in 1 to 4 weeks to a Registro Sanitario that can take 18 months to issue. Here's what each one is, who holds it, and how long it takes.

Where Tally Global fits

Tally Global operates as the Mexico-side operations partner for US brands going through this process. They hold the S. de R.L. de C.V. structure, manage the RFC and eFirma, file the monthly SAT declarations, coordinate the COFEPRIS dossier with regulatory consultants, and act as IOR for first shipments. For brands that don't want to build a Mexico entity from scratch, it's the fastest path to a legitimate compliance stack.

This isn't a model unique to Tally, several IOR and regulatory services operate in Mexico. The evaluation criteria that matter: how many supplement RSs have they successfully filed in the past 24 months? What's their requerimiento rate? Do they maintain a dedicated relationship with a COFEPRIS-credentialed regulatory specialist, or do they outsource it ad hoc?

---

Understanding the supplement market in Mexico: categories worth knowing

Health and wellness ranks among the top purchase categories in Mexico's $43-55B ecommerce market, and the supplements market intelligence report has the full category breakdown. A few highlights relevant to the RS decision:

The probiotics market intelligence report shows strong Mexican consumer demand with limited US brand presence. Probiotic RS filings are more documentation-intensive, strain-level certificates of analysis required, but the category is legitimate and approvable.

The sports nutrition market intelligence report covers a high-growth category with the highest RS complexity. Pre-workouts with stimulants and fat burners with thermogenic compounds frequently trigger medicamento classification reviews. Protein powders and BCAAs are generally straightforward.

The sleep and stress market intelligence report covers a category where adaptogen products face the highest ingredient-level scrutiny. Ashwagandha and rhodiola have been registered successfully in Mexico, but the QQ documentation requirements are detailed.

The kids vitamins market intelligence report is relevant for brands with children's supplement lines. Pediatric supplements face additional labeling requirements and age-appropriate dosing documentation.

---

The functional mushroom opportunity and its regulatory complexity

Functional mushroom supplements carry an RS timeline of 8 to 14 months in Mexico, and the functional mushrooms market intelligence report shows Mexican consumer awareness in lion's mane, reishi, and chaga climbing fast. These products occupy a regulatory gray area, generally approvable as suplemento alimenticio if positioned as nutritional support, but claims around cognitive function or immune modulation require careful label management.

That timeline mirrors herbal blends, with the same QQ documentation requirements. The category window is open, but the label has to be clean.

---

Reformulation as a Mexico entry strategy

A Mexico-specific SKU that keeps 90% of your US formula but removes one problematic ingredient is a legitimate entry strategy, not a compromise. Some US brands assume they'll enter with their exact US formulation, and that's often correct. Sometimes it isn't.

If your US formulation contains an ingredient that's either not on Mexico's permitted list or that triggers a medicamento classification, you have 3 options: reformulate for Mexico, skip Mexico, or file for a complex RS with a higher probability of rejection or long delay.

Reformulating for Mexico isn't as painful as it sounds if you plan for it early. A Mexico-specific SKU that shares most of the US formula but removes one problematic ingredient is a legitimate strategy. Mexican consumers aren't comparing your Mexican label to your US label, they're comparing you to whatever is currently on the shelf. The food and beverage reformulation requirements post covers the reformulation calculus in the food context, and the logic applies directly to supplements. The Mexico isn't Canada post covers the broader set of assumptions that cost US brands time.

---

Running the numbers: is it worth it?

A brand doing $5M in US supplement revenue with 60% gross margin and a well-positioned SKU in a growing Mexican category should expect:

Year 1 Mexico revenue: $100K-$500K (realistic, not a ceiling). Year 2: $300K-$1.5M with distribution and marketplace traction. Year 3: $700K-$3M with brand recognition building.

Against a compliance and launch investment of $25,000-$75,000 (multi-SKU, entity formation included), the ROI math works at year 2 for most brands with a competitive product.

The brands that don't make the math work are the ones that budget only for the RS and ignore the ongoing costs: monthly accountant, annual RS maintenance, label stickering per unit, platform listing fees, and PPC to build organic rank.

These numbers assume the product has genuine demand and the brand is investing in marketing, not just listing and waiting.

---

Use the Mexico Scanner before you file anything

Before you commit $8,000 to a consultant or a dollar to inventory, run your product through the Datahooks Mexico Scanner. The tool evaluates your product against the current COFEPRIS ingredient list, the NOM-051 sello thresholds, and the classification criteria that determine whether you're filing as a suplemento alimenticio or something more complicated.

It won't replace a regulatory consultant for your final filing, but it will tell you in 10 minutes whether you have a straightforward path or a complicated one. That knowledge changes how you budget, how you sequence your SKU selection, and whether you lead with your flagship or with a simpler product first.

---

For supplement brands specifically

For a $3M to $10M US supplement brand weighing Mexico, the supplement brand page covers Datahooks' full research and market intelligence offering for the category. The tools are built for founders making the entry decision, not for regulatory consultants who already know the answers.

---

The comparison most brands don't think to make

A single requerimiento delays your RS by 30-60 business days, which costs more than the consultant fee you avoided by filing without professional help. The doing it yourself comparison is the most honest evaluation of the build-vs-buy decision for Mexico market entry. DIY is possible, brands have done it. The cost isn't money, it's time and the specific cost of errors made by people handling COFEPRIS for the first time.

---

Final assessment

COFEPRIS registration for a US supplement brand is a 4-18 month process with a total compliance cost of $10,000-$75,000 depending on SKU count, entity structure, and product complexity. It's not a barrier that only large brands can clear. It's a process that rewards preparation and punishes improvisation.

The brands currently winning in Mexico's supplement market got there by starting earlier than felt necessary, choosing the right first SKU rather than the most complex one, and building a Mexico-compliant infrastructure that could scale as revenue grew.

The 65 million buyer market is real and it's growing. The regulatory process is manageable. What you need is a clear picture of what it actually requires, and now you have one.

---

Ready to map your specific products against the Mexican market?

Get your Mexico Launch Blueprint at /start and work through the market entry analysis with real data on your category.

Or start with the supplement market intelligence report to understand what the competitive field looks like before you commit to the compliance process.